A biotechnology company struggling to cope with ongoing regulatory and quality requirements.
The client, despite being well-funded with a strong potential product pipeline, lacked the internal expertise to address quality and regulatory aspects of their ongoing development programme.
How our approach made a difference:
We were able to identify and appoint a senior quality expert who was able to highlight the issues they faced, offer guidance and implement corrective actions. As a result of the interim’s expertise and credibility with the various authorities, the company was saved from severe repercussions at a very early stage.